| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/24/2007 | WO2004060266A3 Eye-drop vaccine containing copolymer poly-ye for therapeutic immunization |
| 05/24/2007 | US20070118934 Chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax |
| 05/24/2007 | US20070117970 generating an immune response, comprising administering to a mammal variable major protein (VMP)-like polypeptides as antigens for immunoprophylaxis, immunotherapy and immunodiagnosis; antibodies; Lyme disease |
| 05/24/2007 | US20070117968 Metal binding proteins and associated methods |
| 05/24/2007 | US20070117967 Homogeneous preparations of il-28 and il-29 |
| 05/24/2007 | US20070117753 Contacting a cell with a peptide compound capable of inducing a conformational change in Bcl-2; converting the Bcl-2 into a pro-apoptotic form |
| 05/24/2007 | US20070117189 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 05/24/2007 | US20070117166 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes |
| 05/24/2007 | US20070117165 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/24/2007 | US20070117162 Kidney-specific urate transporter and gene thereof |
| 05/24/2007 | US20070117156 Method of detecting native proBNP |
| 05/24/2007 | US20070117131 Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process |
| 05/24/2007 | US20070117129 Antigen arrays for treatment of bone disease |
| 05/24/2007 | US20070117107 rRNA genes from E. coli and other disease causing organisms are genetically engineered to allow identification of functional mutant ribosomes that may be used as drug targets |
| 05/24/2007 | US20070117091 Anti-candida agents for the treatment of prion diseases |
| 05/24/2007 | US20070116768 Sustained release preparations composed of biocompatible complex microparticles |
| 05/24/2007 | US20070116727 Vaccines directed to cancer-associated carbohydrate antigens |
| 05/24/2007 | US20070116726 Immunisation against Chlamydia pneumoniae |
| 05/24/2007 | US20070116725 Live Attenuated Samonella Strains for Producing Monovalent or Multivalent Vaccines |
| 05/24/2007 | US20070116724 Compositions and Methods of Topical Application and Transdermal Delivery of Botulinum Toxins without Reduced Non-Toxin Proteins |
| 05/24/2007 | US20070116723 Topically applied clostridium botulinum toxin compositions and treatment methods |
| 05/24/2007 | US20070116722 Ovo vaccination of campylobacter in avian species |
| 05/24/2007 | US20070116721 Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof |
| 05/24/2007 | US20070116720 Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| 05/24/2007 | US20070116719 Vaccine delivery |
| 05/24/2007 | US20070116718 Fusion proteins comprising bacteriophage coat protein and asingle-chain T cell receptor |
| 05/24/2007 | US20070116717 Influenza vaccine compositions and methods |
| 05/24/2007 | US20070116716 Sars coronavirus s proteins and uses thereof |
| 05/24/2007 | US20070116715 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 05/24/2007 | US20070116714 Vaccine Comprising a Polysaccharide Antigen-Carrier Protein Conjugate and Free Carrier Protein |
| 05/24/2007 | US20070116712 Novel streptococcus antigens |
| 05/24/2007 | US20070116711 Pertussis antigens and use thereof in vaccination |
| 05/24/2007 | US20070116710 Methods of treating hemolytic anemia |
| 05/24/2007 | US20070116709 Microemulsions with adsorbed macromolecules and microparticles |
| 05/24/2007 | US20070116708 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 05/24/2007 | US20070116707 Antibody and antibody fragments for inhibiting the growth of tumors |
| 05/24/2007 | US20070116706 Antibodies to the propeptide of candida albicans and methods of use |
| 05/24/2007 | US20070116705 NOVEL PDEs AND USES THEREOF |
| 05/24/2007 | US20070116704 Method for the production of an immunostimulating mucin (muc1) |
| 05/24/2007 | US20070116703 Isolated mammalian membrane proteins; related agents |
| 05/24/2007 | US20070116702 Survival promoting NCAM binding and MCAM ligand binding compounds |
| 05/24/2007 | US20070116701 Compositions and methods for diagnosing and treating cancer |
| 05/24/2007 | US20070116700 For subcutaneous administration; hypertonic; useful for preventing self-association of reconstituted lyophilized formulations |
| 05/24/2007 | US20070116698 Novel methods and medicament for treating infectious diseases involving microbial biofilms |
| 05/24/2007 | US20070116689 LIM mineralization protein splice variants |
| 05/24/2007 | US20070116688 Methods of organ regeneration |
| 05/24/2007 | US20070116687 Method of modulating cellular transmigration and agents for use therein |
| 05/24/2007 | US20070116672 Treatment of rheumatic diseases |
| 05/24/2007 | US20070116669 Interferon-inducible protein-10 (IP-10 or CXCL10) chemokine analogs for the treatment of human diseases |
| 05/24/2007 | US20070116645 Methods and compositions for inhibiting cholesterol uptake |
| 05/24/2007 | CA2783210A1 Method for treating joint damage |
| 05/24/2007 | CA2630530A1 Composition comprising a colloidal synthetic bioresorbable vector and a viral vector |
| 05/24/2007 | CA2630349A1 Stabilizing formulations for recombinant viruses |
| 05/24/2007 | CA2629881A1 A compound comprising an autoantigenic peptide and a carrier with a mhc binding motif |
| 05/24/2007 | CA2629786A1 Human bocavirus and methods of diagnosis and treatment |
| 05/24/2007 | CA2629715A1 Anti-alpha2 integrin antibodies and their uses |
| 05/24/2007 | CA2629545A1 Treating inflammatory disorders with antibodies to the alpha-7 nicotinic receptors |
| 05/24/2007 | CA2629499A1 Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins |
| 05/24/2007 | CA2629453A1 Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen |
| 05/24/2007 | CA2629163A1 Adenoviral vector-based foot-and-mouth disease vaccine |
| 05/24/2007 | CA2629095A1 Anti-egfr antibodies |
| 05/24/2007 | CA2628628A1 Rankl antibody-pth/pthrp chimeric molecules |
| 05/24/2007 | CA2627886A1 Method for treating joint damage |
| 05/23/2007 | EP1788087A1 Immunogenic detoxified mutant toxins |
| 05/23/2007 | EP1788086A1 Death Domain Containing Receptor 5 |
| 05/23/2007 | EP1788085A1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 05/23/2007 | EP1787999A1 Anti-VEGF antibodies |
| 05/23/2007 | EP1787998A1 Antibody and utilization of the same |
| 05/23/2007 | EP1787994A1 TB vaccine and diagnostic based on antigens from M. tuberculosis cell |
| 05/23/2007 | EP1787656A1 Recombinant live fowlpox virus vectors and their use in pharmaceutical compositions against hepatitis c virus |
| 05/23/2007 | EP1787655A2 Meningococcal vaccine composition |
| 05/23/2007 | EP1787654A1 A method of inducing a CTL response |
| 05/23/2007 | EP1786931A2 Methods and compositions for measuring natriuretic peptides and uses thereof |
| 05/23/2007 | EP1786918A2 Novel tetravalent bispecific antibody |
| 05/23/2007 | EP1786907A2 Screening assays for inhibitors of a staphylococcus aureus siderophore |
| 05/23/2007 | EP1786904A2 Adenoviral vector compositions |
| 05/23/2007 | EP1786902A2 A novel class of therapeutic protein based molecules |
| 05/23/2007 | EP1786837A2 Antibodies to dkk-1 |
| 05/23/2007 | EP1786787A1 2,4,6-TRIAMINO-S-TRIAZINE-BASED COMPOUNDS WHICH BIND TO THE TAIL (Fc) PORTION OF IMMUNOGLOBULINS AND THEIR USE |
| 05/23/2007 | EP1786464A2 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 05/23/2007 | EP1786463A2 Antibodies against nogo receptor |
| 05/23/2007 | EP1786462A2 Use of parasitic biological agents for prevention and control of allergic and other ige-mediated disorders |
| 05/23/2007 | EP1786461A2 Antibiotic resistance free dna vaccines |
| 05/23/2007 | EP1786460A2 Assay for detecting tuberculosis in nonhuman primates |
| 05/23/2007 | EP1786450A2 Hiv immunostimulatory compositions |
| 05/23/2007 | EP1786444A1 Intradiscal production of autologous interleukin receptor antagonist |
| 05/23/2007 | EP1613752B1 Chimaeric protein containing cysteine protease of liver fluke fused to hepatitis b core protein or ubiquitin, plants expressing said protein, and uses thereof as vaccine |
| 05/23/2007 | EP1530494B1 A pharmaceutical preparation containing palladium complex compounds |
| 05/23/2007 | EP1307537B1 Neospora caninum isolate |
| 05/23/2007 | EP0970203B1 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease in humans |
| 05/23/2007 | EP0873407B1 Apo-2 ligand |
| 05/23/2007 | EP0820469B1 Identification, purification and uses of leczymes and carbohydrate ligands |
| 05/23/2007 | EP0754223B1 Non-pathogenic strains of hiv-1 |
| 05/23/2007 | CN1968716A Methods of treating lung diseases |
| 05/23/2007 | CN1968712A Novel antigen-binding polypeptides and their uses |
| 05/23/2007 | CN1968711A Combination vaccines with low dose of HIB conjugate |
| 05/23/2007 | CN1968710A Stable peptide mimetic of HIV gp41 fusion intermediate |
| 05/23/2007 | CN1968709A VEGF inhibitors for the treatment of malignant pleural effusion |
| 05/23/2007 | CN1966684A Construction of HER2/neu mRNA in vitro transcription vector and use thereof |
| 05/23/2007 | CN1966656A Vaccine inactivation without residue |